| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.039 | 0.8 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |